Why the study?
Pleuropericardial effusions are rare occurrences that present diagnostic challenges, prompting a recommended approach for the diagnosis and management of pleuropericardial syndrome.
Colchicine monotherapy may be an effective alternative for treating idiopathic recurrent serositis in patients intolerant to NSAIDs.
Colchicine monotherapy controlled IRS after NSAID intolerance; case-level evidence leaves open need for prospective confirmation.
A 63-year-old female presented with chest pain and fever, and was found to have recurrent pleuropericardial effusions. Extensive investigations including infection screen and serologies, autoimmune screen and pleural and pericardial biopsy revealed no secondary aetiologies. She was diagnosed with idiopathic recurrent serositis (IRS). Our patient developed rash to naproxen, so she was started on colchicine monotherapy and responded well clinically. A review of the literature demonstrated that pleuropericardial effusions are rare occurrences, with patients occasionally being perceived as a medical enigma. This case study recommends an approach to guide physicians in their diagnosis and management of patients with pleuropericardial syndrome. Our case had an inflammatory phenotype, either autoimmune or seronegative serositis of unclear aetiology, which was recurrent and required pharmacological treatment. While the treatment for IRS lies in combined therapy with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and colchicine, monotherapy with colchicine was effective in the treatment and preventing recurrence in our unique case.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: